Axsome Therapeutics (AXSM) Assets (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.45% |
| Dec 31, 2025 | 3.07% |
| Sep 30, 2025 | 4.61% |
| Jun 30, 2025 | 7.23% |
| Mar 31, 2025 | 4.96% |
| Dec 31, 2024 | 1.25% |
| Sep 30, 2024 | 2.41% |
| Jun 30, 2024 | 0.46% |
| Mar 31, 2024 | -7.23% |
| Dec 31, 2023 | -2.10% |
| Sep 30, 2023 | -1.76% |
| Jun 30, 2023 | 57.16% |
| Mar 31, 2023 | 17.41% |
| Dec 31, 2022 | -2.21% |
| Sep 30, 2022 | 87.73% |
| Jun 30, 2022 | 103.88% |
| Mar 31, 2022 | 0.88% |
| Dec 31, 2021 | -24.71% |
| Sep 30, 2021 | -18.61% |
| Jun 30, 2021 | -14.16% |
| Mar 31, 2021 | -10.33% |
| Dec 31, 2020 | -8.59% |
| Sep 30, 2020 | 6.62% |
| Jun 30, 2020 | -3.44% |
| Mar 31, 2020 | -10.31% |
| Dec 31, 2019 | 396.29% |
| Sep 30, 2019 | -18.87% |
| Jun 30, 2019 | 24.78% |
| Mar 31, 2019 | 185.46% |
| Dec 31, 2018 | -4.63% |
| Sep 30, 2018 | -25.77% |
| Jun 30, 2018 | -22.24% |
| Mar 31, 2018 | -21.42% |
| Dec 31, 2017 | 9.01% |
| Sep 30, 2017 | -16.46% |
| Jun 30, 2017 | -15.88% |
| Mar 31, 2017 | 21.46% |
| Dec 31, 2016 | 9.43% |
| Sep 30, 2016 | -12.72% |
| Jun 30, 2016 | -11.39% |
| Mar 31, 2016 | -8.00% |